Molecular Influenza Test Market, Global Outlook and Forecast 2022-2028

Rapid molecular assays are a kind of molecular influenza diagnostic test to detect influenza virus nucleic acids in upper respiratory tract specimens with high sensitivity (90-95%) and specificity. FDA-cleared rapid molecular assays are available that produce results in approximately 15-30 minutes. Some of these rapid molecular assays are CLIA-waived for point-of-care use.
This report contains market size and forecasts of Molecular Influenza Test in Global, including the following market information:
Global Molecular Influenza Test Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Molecular Influenza Test market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
RT-PCR Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Molecular Influenza Test include F. Hoffmann-La Roche, Quidel Corporation, Thermo Fisher Scientific, Abbott Laboratories, Becton, Dickinson, and Company, DiaSorin and bioM?rieux, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Molecular Influenza Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Influenza Test Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Molecular Influenza Test Market Segment Percentages, by Type, 2021 (%)
Global Molecular Influenza Test Market Segment Percentages, by Application, 2021 (%)
Global Molecular Influenza Test Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Molecular Influenza Test revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Molecular Influenza Test revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Molecular Influenza Test in Global, including the following market information:
Global Molecular Influenza Test Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Molecular Influenza Test market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
RT-PCR Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Molecular Influenza Test include F. Hoffmann-La Roche, Quidel Corporation, Thermo Fisher Scientific, Abbott Laboratories, Becton, Dickinson, and Company, DiaSorin and bioM?rieux, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Molecular Influenza Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Influenza Test Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Molecular Influenza Test Market Segment Percentages, by Type, 2021 (%)
- RT-PCR
- TMA
- LAMP
- NASBA
- Other
Global Molecular Influenza Test Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Clinical Laboratories
- Other End-User
Global Molecular Influenza Test Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Molecular Influenza Test revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Molecular Influenza Test revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- F. Hoffmann-La Roche
- Quidel Corporation
- Thermo Fisher Scientific
- Abbott Laboratories
- Becton, Dickinson, and Company
- DiaSorin
- bioM?rieux
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Molecular Influenza Test Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Influenza Test Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL MOLECULAR INFLUENZA TEST OVERALL MARKET SIZE
2.1 Global Molecular Influenza Test Market Size: 2021 VS 2028
2.2 Global Molecular Influenza Test Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Molecular Influenza Test Players in Global Market
3.2 Top Global Molecular Influenza Test Companies Ranked by Revenue
3.3 Global Molecular Influenza Test Revenue by Companies
3.4 Top 3 and Top 5 Molecular Influenza Test Companies in Global Market, by Revenue in 2021
3.5 Global Companies Molecular Influenza Test Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Influenza Test Players in Global Market
3.6.1 List of Global Tier 1 Molecular Influenza Test Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Influenza Test Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Molecular Influenza Test Market Size Markets, 2021 & 2028
4.1.2 RT-PCR
4.1.3 TMA
4.1.4 LAMP
4.1.5 NASBA
4.1.6 Other
4.2 By Type - Global Molecular Influenza Test Revenue & Forecasts
4.2.1 By Type - Global Molecular Influenza Test Revenue, 2017-2022
4.2.2 By Type - Global Molecular Influenza Test Revenue, 2023-2028
4.2.3 By Type - Global Molecular Influenza Test Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Molecular Influenza Test Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinical Laboratories
5.1.4 Other End-User
5.2 By Application - Global Molecular Influenza Test Revenue & Forecasts
5.2.1 By Application - Global Molecular Influenza Test Revenue, 2017-2022
5.2.2 By Application - Global Molecular Influenza Test Revenue, 2023-2028
5.2.3 By Application - Global Molecular Influenza Test Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Molecular Influenza Test Market Size, 2021 & 2028
6.2 By Region - Global Molecular Influenza Test Revenue & Forecasts
6.2.1 By Region - Global Molecular Influenza Test Revenue, 2017-2022
6.2.2 By Region - Global Molecular Influenza Test Revenue, 2023-2028
6.2.3 By Region - Global Molecular Influenza Test Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Molecular Influenza Test Revenue, 2017-2028
6.3.2 US Molecular Influenza Test Market Size, 2017-2028
6.3.3 Canada Molecular Influenza Test Market Size, 2017-2028
6.3.4 Mexico Molecular Influenza Test Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Molecular Influenza Test Revenue, 2017-2028
6.4.2 Germany Molecular Influenza Test Market Size, 2017-2028
6.4.3 France Molecular Influenza Test Market Size, 2017-2028
6.4.4 U.K. Molecular Influenza Test Market Size, 2017-2028
6.4.5 Italy Molecular Influenza Test Market Size, 2017-2028
6.4.6 Russia Molecular Influenza Test Market Size, 2017-2028
6.4.7 Nordic Countries Molecular Influenza Test Market Size, 2017-2028
6.4.8 Benelux Molecular Influenza Test Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Molecular Influenza Test Revenue, 2017-2028
6.5.2 China Molecular Influenza Test Market Size, 2017-2028
6.5.3 Japan Molecular Influenza Test Market Size, 2017-2028
6.5.4 South Korea Molecular Influenza Test Market Size, 2017-2028
6.5.5 Southeast Asia Molecular Influenza Test Market Size, 2017-2028
6.5.6 India Molecular Influenza Test Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Molecular Influenza Test Revenue, 2017-2028
6.6.2 Brazil Molecular Influenza Test Market Size, 2017-2028
6.6.3 Argentina Molecular Influenza Test Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Influenza Test Revenue, 2017-2028
6.7.2 Turkey Molecular Influenza Test Market Size, 2017-2028
6.7.3 Israel Molecular Influenza Test Market Size, 2017-2028
6.7.4 Saudi Arabia Molecular Influenza Test Market Size, 2017-2028
6.7.5 UAE Molecular Influenza Test Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 F. Hoffmann-La Roche
7.1.1 F. Hoffmann-La Roche Corporate Summary
7.1.2 F. Hoffmann-La Roche Business Overview
7.1.3 F. Hoffmann-La Roche Molecular Influenza Test Major Product Offerings
7.1.4 F. Hoffmann-La Roche Molecular Influenza Test Revenue in Global Market (2017-2022)
7.1.5 F. Hoffmann-La Roche Key News
7.2 Quidel Corporation
7.2.1 Quidel Corporation Corporate Summary
7.2.2 Quidel Corporation Business Overview
7.2.3 Quidel Corporation Molecular Influenza Test Major Product Offerings
7.2.4 Quidel Corporation Molecular Influenza Test Revenue in Global Market (2017-2022)
7.2.5 Quidel Corporation Key News
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Corporate Summary
7.3.2 Thermo Fisher Scientific Business Overview
7.3.3 Thermo Fisher Scientific Molecular Influenza Test Major Product Offerings
7.3.4 Thermo Fisher Scientific Molecular Influenza Test Revenue in Global Market (2017-2022)
7.3.5 Thermo Fisher Scientific Key News
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Corporate Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories Molecular Influenza Test Major Product Offerings
7.4.4 Abbott Laboratories Molecular Influenza Test Revenue in Global Market (2017-2022)
7.4.5 Abbott Laboratories Key News
7.5 Becton, Dickinson, and Company
7.5.1 Becton, Dickinson, and Company Corporate Summary
7.5.2 Becton, Dickinson, and Company Business Overview
7.5.3 Becton, Dickinson, and Company Molecular Influenza Test Major Product Offerings
7.5.4 Becton, Dickinson, and Company Molecular Influenza Test Revenue in Global Market (2017-2022)
7.5.5 Becton, Dickinson, and Company Key News
7.6 DiaSorin
7.6.1 DiaSorin Corporate Summary
7.6.2 DiaSorin Business Overview
7.6.3 DiaSorin Molecular Influenza Test Major Product Offerings
7.6.4 DiaSorin Molecular Influenza Test Revenue in Global Market (2017-2022)
7.6.5 DiaSorin Key News
7.7 bioM?rieux
7.7.1 bioM?rieux Corporate Summary
7.7.2 bioM?rieux Business Overview
7.7.3 bioM?rieux Molecular Influenza Test Major Product Offerings
7.7.4 bioM?rieux Molecular Influenza Test Revenue in Global Market (2017-2022)
7.7.5 bioM?rieux Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Molecular Influenza Test Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Influenza Test Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL MOLECULAR INFLUENZA TEST OVERALL MARKET SIZE
2.1 Global Molecular Influenza Test Market Size: 2021 VS 2028
2.2 Global Molecular Influenza Test Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Molecular Influenza Test Players in Global Market
3.2 Top Global Molecular Influenza Test Companies Ranked by Revenue
3.3 Global Molecular Influenza Test Revenue by Companies
3.4 Top 3 and Top 5 Molecular Influenza Test Companies in Global Market, by Revenue in 2021
3.5 Global Companies Molecular Influenza Test Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Influenza Test Players in Global Market
3.6.1 List of Global Tier 1 Molecular Influenza Test Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Influenza Test Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Molecular Influenza Test Market Size Markets, 2021 & 2028
4.1.2 RT-PCR
4.1.3 TMA
4.1.4 LAMP
4.1.5 NASBA
4.1.6 Other
4.2 By Type - Global Molecular Influenza Test Revenue & Forecasts
4.2.1 By Type - Global Molecular Influenza Test Revenue, 2017-2022
4.2.2 By Type - Global Molecular Influenza Test Revenue, 2023-2028
4.2.3 By Type - Global Molecular Influenza Test Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Molecular Influenza Test Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinical Laboratories
5.1.4 Other End-User
5.2 By Application - Global Molecular Influenza Test Revenue & Forecasts
5.2.1 By Application - Global Molecular Influenza Test Revenue, 2017-2022
5.2.2 By Application - Global Molecular Influenza Test Revenue, 2023-2028
5.2.3 By Application - Global Molecular Influenza Test Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Molecular Influenza Test Market Size, 2021 & 2028
6.2 By Region - Global Molecular Influenza Test Revenue & Forecasts
6.2.1 By Region - Global Molecular Influenza Test Revenue, 2017-2022
6.2.2 By Region - Global Molecular Influenza Test Revenue, 2023-2028
6.2.3 By Region - Global Molecular Influenza Test Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Molecular Influenza Test Revenue, 2017-2028
6.3.2 US Molecular Influenza Test Market Size, 2017-2028
6.3.3 Canada Molecular Influenza Test Market Size, 2017-2028
6.3.4 Mexico Molecular Influenza Test Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Molecular Influenza Test Revenue, 2017-2028
6.4.2 Germany Molecular Influenza Test Market Size, 2017-2028
6.4.3 France Molecular Influenza Test Market Size, 2017-2028
6.4.4 U.K. Molecular Influenza Test Market Size, 2017-2028
6.4.5 Italy Molecular Influenza Test Market Size, 2017-2028
6.4.6 Russia Molecular Influenza Test Market Size, 2017-2028
6.4.7 Nordic Countries Molecular Influenza Test Market Size, 2017-2028
6.4.8 Benelux Molecular Influenza Test Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Molecular Influenza Test Revenue, 2017-2028
6.5.2 China Molecular Influenza Test Market Size, 2017-2028
6.5.3 Japan Molecular Influenza Test Market Size, 2017-2028
6.5.4 South Korea Molecular Influenza Test Market Size, 2017-2028
6.5.5 Southeast Asia Molecular Influenza Test Market Size, 2017-2028
6.5.6 India Molecular Influenza Test Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Molecular Influenza Test Revenue, 2017-2028
6.6.2 Brazil Molecular Influenza Test Market Size, 2017-2028
6.6.3 Argentina Molecular Influenza Test Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Influenza Test Revenue, 2017-2028
6.7.2 Turkey Molecular Influenza Test Market Size, 2017-2028
6.7.3 Israel Molecular Influenza Test Market Size, 2017-2028
6.7.4 Saudi Arabia Molecular Influenza Test Market Size, 2017-2028
6.7.5 UAE Molecular Influenza Test Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 F. Hoffmann-La Roche
7.1.1 F. Hoffmann-La Roche Corporate Summary
7.1.2 F. Hoffmann-La Roche Business Overview
7.1.3 F. Hoffmann-La Roche Molecular Influenza Test Major Product Offerings
7.1.4 F. Hoffmann-La Roche Molecular Influenza Test Revenue in Global Market (2017-2022)
7.1.5 F. Hoffmann-La Roche Key News
7.2 Quidel Corporation
7.2.1 Quidel Corporation Corporate Summary
7.2.2 Quidel Corporation Business Overview
7.2.3 Quidel Corporation Molecular Influenza Test Major Product Offerings
7.2.4 Quidel Corporation Molecular Influenza Test Revenue in Global Market (2017-2022)
7.2.5 Quidel Corporation Key News
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Corporate Summary
7.3.2 Thermo Fisher Scientific Business Overview
7.3.3 Thermo Fisher Scientific Molecular Influenza Test Major Product Offerings
7.3.4 Thermo Fisher Scientific Molecular Influenza Test Revenue in Global Market (2017-2022)
7.3.5 Thermo Fisher Scientific Key News
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Corporate Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories Molecular Influenza Test Major Product Offerings
7.4.4 Abbott Laboratories Molecular Influenza Test Revenue in Global Market (2017-2022)
7.4.5 Abbott Laboratories Key News
7.5 Becton, Dickinson, and Company
7.5.1 Becton, Dickinson, and Company Corporate Summary
7.5.2 Becton, Dickinson, and Company Business Overview
7.5.3 Becton, Dickinson, and Company Molecular Influenza Test Major Product Offerings
7.5.4 Becton, Dickinson, and Company Molecular Influenza Test Revenue in Global Market (2017-2022)
7.5.5 Becton, Dickinson, and Company Key News
7.6 DiaSorin
7.6.1 DiaSorin Corporate Summary
7.6.2 DiaSorin Business Overview
7.6.3 DiaSorin Molecular Influenza Test Major Product Offerings
7.6.4 DiaSorin Molecular Influenza Test Revenue in Global Market (2017-2022)
7.6.5 DiaSorin Key News
7.7 bioM?rieux
7.7.1 bioM?rieux Corporate Summary
7.7.2 bioM?rieux Business Overview
7.7.3 bioM?rieux Molecular Influenza Test Major Product Offerings
7.7.4 bioM?rieux Molecular Influenza Test Revenue in Global Market (2017-2022)
7.7.5 bioM?rieux Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Molecular Influenza Test Market Opportunities & Trends in Global Market
Table 2. Molecular Influenza Test Market Drivers in Global Market
Table 3. Molecular Influenza Test Market Restraints in Global Market
Table 4. Key Players of Molecular Influenza Test in Global Market
Table 5. Top Molecular Influenza Test Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Molecular Influenza Test Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Molecular Influenza Test Revenue Share by Companies, 2017-2022
Table 8. Global Companies Molecular Influenza Test Product Type
Table 9. List of Global Tier 1 Molecular Influenza Test Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Molecular Influenza Test Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Molecular Influenza Test Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Molecular Influenza Test Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Molecular Influenza Test Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Molecular Influenza Test Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Molecular Influenza Test Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Molecular Influenza Test Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Molecular Influenza Test Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Molecular Influenza Test Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Molecular Influenza Test Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Molecular Influenza Test Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Molecular Influenza Test Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Molecular Influenza Test Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Molecular Influenza Test Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Molecular Influenza Test Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Molecular Influenza Test Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Molecular Influenza Test Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Molecular Influenza Test Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Molecular Influenza Test Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Molecular Influenza Test Revenue, (US$, Mn), 2023-2028
Table 30. F. Hoffmann-La Roche Corporate Summary
Table 31. F. Hoffmann-La Roche Molecular Influenza Test Product Offerings
Table 32. F. Hoffmann-La Roche Molecular Influenza Test Revenue (US$, Mn), (2017-2022)
Table 33. Quidel Corporation Corporate Summary
Table 34. Quidel Corporation Molecular Influenza Test Product Offerings
Table 35. Quidel Corporation Molecular Influenza Test Revenue (US$, Mn), (2017-2022)
Table 36. Thermo Fisher Scientific Corporate Summary
Table 37. Thermo Fisher Scientific Molecular Influenza Test Product Offerings
Table 38. Thermo Fisher Scientific Molecular Influenza Test Revenue (US$, Mn), (2017-2022)
Table 39. Abbott Laboratories Corporate Summary
Table 40. Abbott Laboratories Molecular Influenza Test Product Offerings
Table 41. Abbott Laboratories Molecular Influenza Test Revenue (US$, Mn), (2017-2022)
Table 42. Becton, Dickinson, and Company Corporate Summary
Table 43. Becton, Dickinson, and Company Molecular Influenza Test Product Offerings
Table 44. Becton, Dickinson, and Company Molecular Influenza Test Revenue (US$, Mn), (2017-2022)
Table 45. DiaSorin Corporate Summary
Table 46. DiaSorin Molecular Influenza Test Product Offerings
Table 47. DiaSorin Molecular Influenza Test Revenue (US$, Mn), (2017-2022)
Table 48. bioMerieux Corporate Summary
Table 49. bioMerieux Molecular Influenza Test Product Offerings
Table 50. bioMerieux Molecular Influenza Test Revenue (US$, Mn), (2017-2022)
Table 1. Molecular Influenza Test Market Opportunities & Trends in Global Market
Table 2. Molecular Influenza Test Market Drivers in Global Market
Table 3. Molecular Influenza Test Market Restraints in Global Market
Table 4. Key Players of Molecular Influenza Test in Global Market
Table 5. Top Molecular Influenza Test Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Molecular Influenza Test Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Molecular Influenza Test Revenue Share by Companies, 2017-2022
Table 8. Global Companies Molecular Influenza Test Product Type
Table 9. List of Global Tier 1 Molecular Influenza Test Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Molecular Influenza Test Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Molecular Influenza Test Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Molecular Influenza Test Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Molecular Influenza Test Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Molecular Influenza Test Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Molecular Influenza Test Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Molecular Influenza Test Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Molecular Influenza Test Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Molecular Influenza Test Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Molecular Influenza Test Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Molecular Influenza Test Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Molecular Influenza Test Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Molecular Influenza Test Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Molecular Influenza Test Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Molecular Influenza Test Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Molecular Influenza Test Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Molecular Influenza Test Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Molecular Influenza Test Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Molecular Influenza Test Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Molecular Influenza Test Revenue, (US$, Mn), 2023-2028
Table 30. F. Hoffmann-La Roche Corporate Summary
Table 31. F. Hoffmann-La Roche Molecular Influenza Test Product Offerings
Table 32. F. Hoffmann-La Roche Molecular Influenza Test Revenue (US$, Mn), (2017-2022)
Table 33. Quidel Corporation Corporate Summary
Table 34. Quidel Corporation Molecular Influenza Test Product Offerings
Table 35. Quidel Corporation Molecular Influenza Test Revenue (US$, Mn), (2017-2022)
Table 36. Thermo Fisher Scientific Corporate Summary
Table 37. Thermo Fisher Scientific Molecular Influenza Test Product Offerings
Table 38. Thermo Fisher Scientific Molecular Influenza Test Revenue (US$, Mn), (2017-2022)
Table 39. Abbott Laboratories Corporate Summary
Table 40. Abbott Laboratories Molecular Influenza Test Product Offerings
Table 41. Abbott Laboratories Molecular Influenza Test Revenue (US$, Mn), (2017-2022)
Table 42. Becton, Dickinson, and Company Corporate Summary
Table 43. Becton, Dickinson, and Company Molecular Influenza Test Product Offerings
Table 44. Becton, Dickinson, and Company Molecular Influenza Test Revenue (US$, Mn), (2017-2022)
Table 45. DiaSorin Corporate Summary
Table 46. DiaSorin Molecular Influenza Test Product Offerings
Table 47. DiaSorin Molecular Influenza Test Revenue (US$, Mn), (2017-2022)
Table 48. bioMerieux Corporate Summary
Table 49. bioMerieux Molecular Influenza Test Product Offerings
Table 50. bioMerieux Molecular Influenza Test Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Molecular Influenza Test Segment by Type in 2021
Figure 2. Molecular Influenza Test Segment by Application in 2021
Figure 3. Global Molecular Influenza Test Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Molecular Influenza Test Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Molecular Influenza Test Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Molecular Influenza Test Revenue in 2021
Figure 8. By Type - Global Molecular Influenza Test Revenue Market Share, 2017-2028
Figure 9. By Application - Global Molecular Influenza Test Revenue Market Share, 2017-2028
Figure 10. By Region - Global Molecular Influenza Test Revenue Market Share, 2017-2028
Figure 11. By Country - North America Molecular Influenza Test Revenue Market Share, 2017-2028
Figure 12. US Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Molecular Influenza Test Revenue Market Share, 2017-2028
Figure 16. Germany Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 17. France Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Molecular Influenza Test Revenue Market Share, 2017-2028
Figure 24. China Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 28. India Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Molecular Influenza Test Revenue Market Share, 2017-2028
Figure 30. Brazil Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Molecular Influenza Test Revenue Market Share, 2017-2028
Figure 33. Turkey Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 37. F. Hoffmann-La Roche Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Quidel Corporation Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Thermo Fisher Scientific Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Abbott Laboratories Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Becton, Dickinson, and Company Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. DiaSorin Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. bioMerieux Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Molecular Influenza Test Segment by Type in 2021
Figure 2. Molecular Influenza Test Segment by Application in 2021
Figure 3. Global Molecular Influenza Test Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Molecular Influenza Test Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Molecular Influenza Test Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Molecular Influenza Test Revenue in 2021
Figure 8. By Type - Global Molecular Influenza Test Revenue Market Share, 2017-2028
Figure 9. By Application - Global Molecular Influenza Test Revenue Market Share, 2017-2028
Figure 10. By Region - Global Molecular Influenza Test Revenue Market Share, 2017-2028
Figure 11. By Country - North America Molecular Influenza Test Revenue Market Share, 2017-2028
Figure 12. US Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Molecular Influenza Test Revenue Market Share, 2017-2028
Figure 16. Germany Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 17. France Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Molecular Influenza Test Revenue Market Share, 2017-2028
Figure 24. China Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 28. India Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Molecular Influenza Test Revenue Market Share, 2017-2028
Figure 30. Brazil Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Molecular Influenza Test Revenue Market Share, 2017-2028
Figure 33. Turkey Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Molecular Influenza Test Revenue, (US$, Mn), 2017-2028
Figure 37. F. Hoffmann-La Roche Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Quidel Corporation Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Thermo Fisher Scientific Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Abbott Laboratories Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Becton, Dickinson, and Company Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. DiaSorin Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. bioMerieux Molecular Influenza Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)